LegalizeThe Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002
Information about previous releases of the genetically modified higher plant, if applicable.
38
The name and address of the applicant, and the name, qualifications and experience of the scientist and of every other person who will be responsible for planning and carrying out the release of the organisms, and for the supervision, monitoring and safety of the release.
39
The designation and specification of the genetically modified higher plant.
40
The scope of the notification including—
- (a) cultivation
- (b) any other use.
PART VIII — INFORMATION ON METHODOLOGY
41
The complete name of the plant, that is—
- (a) family name,
- (b) genus,
- (c) species,
- (d) subspecies,
- (e) cultivar/breeding line, and
- (f) common name.
SCHEDULE 3 — INFORMATION TO BE INCLUDED IN APPLICATIONS FOR CONSENT TO RELEASE OR MARKET ORGANISMS OTHER THAN GENETICALLY MODIFIED HIGHER PLANTS
PART I — GENERAL INFORMATION
1
The name and address of the applicant, and the name, qualifications and experience of the scientist and of every other person who will be responsible for planning and carrying out the release of the organisms, and for the supervision, monitoring and safety of the release.
2
The title of the project.
PART II — INFORMATION RELATING TO THE ORGANISMS
Characteristics of donor, parental and recipient organisms
3
Scientific name and taxonomy.
4
Usual strain, cultivar or other name.
5
Phenotypic and genetic markers.
6
The degree of relatedness between donor and recipient or between parental organisms.
7
The description of identification and detection techniques.
8
The sensitivity, reliability (in quantitative terms) and specificity of detection and identification techniques.
9
The description of the geographic distribution and of the natural habitat of the organisms including information on natural predators, prey, parasites and competitors, symbionts and hosts.
10
The organisms with which transfer of genetic material is known to occur under natural conditions.
11
Verification of the genetic stability of the organisms and factors affecting that stability.
12
The following pathological, ecological and physiological traits:–
- (a) the classification of hazard according to existing Community rules concerning the protection of human health and the environment;
- (b) the generation time in natural ecosystems, sexual and asexual reproductive cycle;
- (c) information on survivability, including seasonability and the ability to form survival structures, including seeds, spores and sclerotia;
- (d) pathogencity, including infectivity, toxigenicity, virulence, allergenicity, carrier (vector) of pathogen, possible vectors, host range including non-target organisms and possible activation of latent viruses (proviruses) and ability to colonise other organisms;
- (e) antibiotic resistance, and potential use of these antibiotics in humans and domestic organisms for prophylaxis and therapy; and
- (f) involvement in environmental processes, including primary production, nutrient turnover, decomposition of organic matter and respiration.
13
The sequence, frequency of mobilisation and specificity of indigenous vectors, and the presence in those vectors of genes which confer resistance to environmental stresses.
14
The history of genetic modifications.
Characteristics of the vector
15
The nature and source of the vector.
16
The sequence of transposons, vectors and other non-coding genetic segments used to construct the genetically modified organisms and to make the introduced vector and insert function in those organisms.
17
The frequency of mobilisation, genetic transfer capabilities and/or methods of determination of the inserted vector.
18
Information on the degree to which the vector is limited to the DNA required to perform the intended function.
Characteristics of the modified organisms
19
The methods used for the modification.
20
The methods used–
- (a) to construct inserts and to introduce them into the recipient organism; and
- (b) to delete a sequence.
21
The description of any insert and/or vector construction.
22
The purity of the insert from any unknown sequence and information on the degree to which the inserted sequence is limited to the DNA required to perform the intended function.
23
The methods and criteria used for selection.
24
The sequence, functional identity and location of the altered, inserted or deleted nucleic acid segment or segments in question, and in particular any known harmful sequence.
Characteristics of the genetically modified organisms in their final form
25
The description of genetic traits or phenotypic characteristics and in particular any new traits and characteristics which may be expressed or no longer expressed.
26
The structure and amount of any vector or donor nucleic acid remaining in the final construction of the modified organism.
27
The stability of the organism in terms of genetic traits.
28
The rate and level of expression of the new genetic material in the organism, and the method and sensitivity of measurement of that rate and level.
29
The activity of the expressed protein.
30
The description of identification and detection techniques, including techniques for the identification and detection of the inserted sequence and vector.
31
The sensitivity, reliability (in quantitative terms), and specificity of detection and identification techniques.
32
The history of previous releases or uses of the genetically modified organisms.
33
In relation to human health, animal health and plant health–
- (a) the toxic or allergenic effects of the organisms and/or their metabolic products;
- (b) the comparison of the modified organism to the donor, recipient or (where appropriate) parental organism regarding pathogenicity;
- (c) the capacity of the organisms for colonisation;
- (d) if the organism is pathogenic to humans who are immunocompetent–
- (i) diseases caused and mechanism of pathogenicity including invasiveness and virulence;
- (ii) communicability;
- (iii) infective dose;
- (iv) host range and possibility of alteration;
- (v) possibility of survival outside of human host;
- (vi) presence of vectors or means of dissemination;
- (vii) biological stability;
- (viii) antibiotic resistance patterns;
- (ix) allergenicity; and
- (x) availability of appropriate therapies; and
- (e) the other product hazards.
PART III — INFORMATION RELATING TO THE CONDITIONS OF RELEASE AND THE RECEIVING ENVIRONMENT
The release
34
The description of the proposed deliberate release, including the purpose of the release and the foreseen products of the release.
35
The foreseen dates of the release and time planning of the experiment including frequency and duration of releases.
36
The preparation of the site before the release.
37
The size of the site.
38
The methods to be used for the release.
39
The quantity of organisms to be released.
40
The disturbance of the site, including the type and method of cultivation, mining, irrigation or other activities.
41
The worker protection measures taken during the release.
42
The post-release treatment of the site.
43
The techniques foreseen for elimination or inactivation of the genetically modified organisms at the end of the experiment or other purpose of the release.
44
Information on, and the results of, previous releases of the organisms, and in particular, releases on a different scale or into different ecosystems.
The environment (both on the site and in the wider environment)
45
The geographical location and national grid reference of the site onto which the release will be made, or in the case of applications for consent to market or renewed consent to market the foreseen areas of use of the product.
46
The physical or biological proximity of the site of the organisms to humans and other significant biota.
47
The proximity to significant biotopes, protected areas or drinking water supplies.
48
The climatic characteristics of the region or regions likely to be affected.
49
The geographical, geological and pedological characteristics.
50
The flora and fauna, including crops, livestock and migratory species.
51
The description of the target and non-target ecosystems likely to be affected.
52
A comparison of the natural habitat of the recipient organism with the proposed site or sites of release.
53
Any known planned developments or changes in land use in the region which could influence the environmental impact of the release.
PART IV — INFORMATION RELATING TO THE INTERACTIONS BETWEEN THE GENETICALLY MODIFIED ORGANISMS AND THE ENVIRONMENT
Characteristics affecting survival, multiplication and dissemination
54
The biological features which affect survival, multiplication and dispersal.
55
The known or predicted environmental conditions which may affect survival, multiplication and dissemination, including wind, water, soil, temperature and pH.
56
The sensitivity to specific agents.
Interactions with the environment
57
The predicted habitat of the genetically modified organisms.
58
The studies on the behaviour and characteristics of the genetically modified organisms and their ecological impact carried out in simulated natural environments, such as microcosms, growth rooms and greenhouses.
59
The capability of post-release transfer of genetic material–
- (a) from the genetically modified organisms into organisms in affected ecosystems;
- (b) from indigenous organisms to the genetically modified organisms.
60
The likelihood of post-release selection leading to the expression of unexpected and/or undesirable traits in the genetically modified organism.
61
The measures employed to ensure and to verify genetic stability, the description of genetic traits which may prevent or minimise dispersal of genetic material, and methods to verify genetic stability.
62
The routes of biological dispersal, known or potential modes of interaction with the disseminating agent, including inhalation, ingestion, surface contact and burrowing.
63
The description of ecosystems to which the genetically modified organisms could be disseminated.
64
The potential for excessive population increase of the genetically modified organisms in the environment.
65
The competitive advantage of the genetically modified organisms in relation to the unmodified recipient or parental organisms.
66
The identification and description of the target organisms if applicable.
67
The anticipated mechanism and result of interaction between the released genetically modified organisms and the target organisms, if applicable.
68
The identification and description of non-target organisms which may be adversely affected by the release of the genetically modified organism, and the anticipated mechanisms of any identified adverse interaction.
69
The likelihood of post release shifts in biological interactions or in the host range.
70
The known or predicted interactions with non-target organisms in the environment, including competitors, preys, hosts, symbionts, predators, parasites and pathogens.
71
The known or predicted involvement of the genetically modified organisms in biogeochemical processes.
72
Any other potential interactions of the organisms with the environment.
PART V — INFORMATION ON MONITORING, CONTROL, WASTE TREATMENT AND EMERGENCY RESPONSE PLANS
Monitoring techniques
73
Methods for tracing the genetically modified organisms and for monitoring their effects.
74
Specificity (to identify the genetically modified organisms, and to distinguish them from the donor, recipient or, where appropriate, the parental organisms), sensitivity and reliability of the monitoring techniques.
75
Techniques for detecting transfer of the donated genetic material to other organisms.
76
Duration and frequency of the monitoring.
Control of the release
77
Methods and procedures to avoid and/or minimise the spread of the genetically modified organisms beyond the site of release or the designated area for use.
78
Methods and procedures to protect the site from intrusion by unauthorised individuals.
79
Methods and procedures to prevent other organisms from entering the site.
Waste treatment
80
Type of waste generated.
81
Expected amount of waste.
82
Description of treatment envisaged.
Emergency response plans
83
Methods and procedures for controlling the genetically modified organisms in case of unexpected spread.
84
Methods, such as eradication of the genetically modified organisms, for decontamination of the areas affected.
85
Methods for disposal or sanitation of plants, animals, soils, and any other thing exposed during or after the spread.
86
Methods for the isolation of the area affected by the spread.
87
Plans for protecting human health and the environment in case of the occurrence of an undesirable effect.
PART VI — INFORMATION ON METHODOLOGY
88
A description of the methods used or a reference to standardised or internationally recognised methods used to compile the information required by this Schedule, and the name of the body or bodies responsible for carrying out the studies.
SCHEDULE 4 — INFORMATION TO BE INCLUDED IN APPLICATIONS FOR CONSENT TO MARKET GENETICALLY MODIFIED ORGANISMS
PART I — GENERAL INFORMATION
1
The proposed commercial name of the product or products (which must be provided to the Scottish Ministers after consent has been granted) and name or names of the genetically modified organism or organisms in the product or products, and a proposal for a unique identifier of the genetically modified organism developed in accordance with Commission Regulation (EC) No 65/2004 establishing a system for the development and assignment of unique identifiers for genetically modified organisms.
2
The name and address ... of the person who is responsible for the placing on the market, whether it be the manufacturer, importer or distributor.
3
The name and address of the supplier of control samples.
4
A description of how the product and the genetically modified organism as or in the product are intended to be used, highlighting any differences in use or management of the genetically modified organism compared to similar non-genetically modified products.
5
A description of the geographical area and types of environment where the product is intended to be used ..., including, where possible, an estimate of the scale of use in each area.
6
A description of the intended categories of users of the product, such as industry, agriculture, skilled trades or consumer use by the public at large.
7
Methods for the detection, identification and, where appropriate, quantification of the transformation event, samples of the genetically modified organism or organisms and their control samples, and information as to the place where the reference material can be accessed (identifying any such information that cannot be placed, for confidentiality reasons, in the register).
8
Information regarding proposed labelling, which must include, in a label or an accompanying document, at least in summarised form, a commercial name of the product, a statement that “This product contains genetically modified organisms”, the name of the genetically modified organism and the name and address of the person ... who is responsible for the placing on the market, and how to access the information in the publicly accessible part of the register.
PART II — ADDITIONAL RELEVANT INFORMATION
9
The measures to be taken in the event of the escape of the organisms in the product or misuse of the product.
10
Specific instructions or recommendations for storage and handling of the product.
11
Specific instructions for carrying out monitoring and reporting to the applicant and, if required, the Scottish Ministers, which are consistent with Part C of schedule 5A, so that the Scottish Ministers can be effectively informed of any adverse effect.
12
The proposed restrictions in the approved use of the genetically modified organism, such as where the product may be used and for what purposes.
13
The proposed packaging.
14
The estimated production in and/or imports to Scotland and other parts of the United Kingdom.
15
Any proposed additional labelling, which may include, at least in summarised form, the information referred to in paragraphs 4 and 5 of Part I of this Schedule, or paragraphs 9 to 12 of this Part.
SCHEDULE 5 — INFORMATION TO BE INCLUDED IN AN ASSESSMENT REPORT
1
An identification of the characteristics of the recipient organism which are relevant to the assessment of the relevant genetically modified organisms.
2
An identification of any known risks to human health and the environment resulting from the release into the environment of the recipient non-modified organism.
3
A description of the result of the genetic modification in the modified organism.
4
An assessment of whether the genetic modification has been characterised sufficiently for the purpose of evaluating any risks to human health and the environment.
5
An identification of any new risks to human health and the environment that may arise from the release of the relevant genetically modified organisms as compared to the release of the corresponding non-modified organism, based on the environmental risk assessment carried out in accordance with regulation 6.
6
A conclusion which addresses the proposed use of the product, risk management and the proposed monitoring plan, and states whether the relevant genetically modified organisms should be placed on the market on its own or in a product and under which conditions, or not placed on the market for reasons which are specified .... Where it is concluded that the genetically modified organisms should not be placed on the market the Scottish Ministers shall give reasons for their conclusion.
SCHEDULE 6 — AMENDMENT TO THE SCOTLAND ACT 1998 (AGENCY ARRANGEMENTS) (SPECIFICATION) (NO. 2) ORDER 2002
For paragraphs (d) and (e) of the Schedule to the Scotland Act 1998 (Agency Arrangements) (Specification) (No. 2) Order 200234 substitute–
(ca) Section 126(5)(b) of the Environmental Protection Act 1990 (function of consulting the Food Standards Agency). (cb) Regulation 16(5) of the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002 (function of consideration whether applicant may omit certain information from an application for consent to market genetically modified organisms). (cc) Regulation 20 of the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002 (functions on receiving applications for consent to release genetically modified organisms). (cd) Regulation 23(1) of the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002 (functions on receipt of applications for consent to market genetically modified organisms). (ce) Regulations 23(4) and 31(4) of the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002 (function of consulting the Health and Safety Executive). (cf) Regulation 27(2) of the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002 (function of evaluating information in environmental risk assessments). (cg) Regulation 35 of the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002 (function of maintaining the register).
SCHEDULE 7 — REVOCATIONS
| Regulations revoked | References | Extent |
|---|---|---|
| The Genetically Modified Organisms (Deliberate Release) Regulations 1992 | S.I. 1992/3280 as amended by the Genetically Modified Organisms (Deliberate Release) Regulations 1993 (S.I. 1993/152), the Genetically Modified Organisms (Deliberate Release) Regulations 1995 (S.I. 1995/304), the Genetically Modified Organisms (Deliberate Release) and Risk Assessment–Amendment) Regulations 1997 (S.I. 1997/1900) and the Genetically Modified Organisms (Contained Use) Regulations 2000 (S.I. 2000/2831) | The whole Regulations other than for the purposes of regulations 9 and 13 of those Regulations |
| The Genetically Modified Organisms (Deliberate Release) Regulations 1993 | S.I. 1993/152 | The whole Regulations |
| The Genetically Modified Organisms (Deliberate Release) Regulations 1995 | S.I. 1995/304 | The whole Regulations |
| The Genetically Modified Organisms (Deliberate Release and Risk Assessment-Amendment) Regulations 1997 | S.I. 1997/1900 | Regulation 2 |
| The Genetically Modified Organisms (Contained Use) Regulations 2000 | S.I. 2000/2831 | Regulation 31(2) |
Signed
ROSS FINNIE — A member of the Scottish Executive — 2002-12-04
Explanatory note
(This note is not part of the Regulations)
Footnotes
1972 c. 68; section 2(2) was amended by the Scotland Act 1998 (c. 46), Schedule 8, paragraph 15(3). The function conferred upon the Minister of the Crown under section 2(2) of the European Communities Act 1972, insofar as within devolved competence, was transferred to the Scottish Ministers by virtue of section 53 of the Scotland Act 1998.
O.J. No. L 117, 8.5.90, p.1.
O.J. No. L 297, 18.11.94, p.29.
O.J. No. L 330, 5.12.98, p.13.
O.J. No. L 106, 17.4.01, p.1.
O.J. No. L 117, 8.5.90, p.15.
O.J. No. L 103, 22.4.94, p.20.
O.J. No. L 169, 27.6.97, p.72.
O.J. No. L 292, 12.11.94, p.31.
Section 106(4) is amended by regulation 3(3) and section 106(4A) to (4D) is inserted by regulation 3(4).
As defined in section 107(2), (3) and (6) of the Act as amended by regulation 4(2) to (4).
S.I. 2000/2831.
O.J. No. L 43, 14.2.97, p.1
O.J. No. L 253, 21.9.01, p.17.
Section 111(6A) was added by S.I. 1992/3280.
As defined in section 107(2), (3) and (6) of the Act as amended by regulation 4(2) to (4).
Section 111(6) of the Act is amended by regulation 19(1).
O.J. No. L 193, 20.7.02, p.1.
O.J. No. L 193, 20.7.02, p.33.
O.J. No. L 11, 15.1.00, p.17.
Section 112(5)(b)(iii) has been inserted by regulation 29(3)(iii).
S.I. 2002/800.
O.J. No. L 214, 24.8.93, p.1.
S.I. 2002/800.
“Regulation 2309/93” means Council Regulation (EEC) No. 2309/1993 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products as amended by–
| EU Instrument | Reference |
|---|---|
| Commission Regulation 1995/542/EC | O.J. No. L 55, 11.3.95, p.15 |
| Commission Regulation 1995/540/EC | O.J. No. L 55, 11.3.95, p.5 |
| Commission Regulation 1996/2141/EC | O.J. No. L 286, 8.11.96, p.6 |
| Commission Regulation 1998/1069/EC | O.J. No. L 153, 27.5.98, p.11 |
| Commission Regulation 1998/649/EC | O.J. No. L 88, 24.3.98, p.7 |
1
The name and address of the applicant, and the name, qualifications and experience of the scientist and of every other person who will be responsible for planning and carrying out the release of the organisms, and for the supervision, monitoring and safety of the release.
2
The title of the project.
1
3
Scientific name and taxonomy.
4
Usual strain, cultivar or other name.
5
Phenotypic and genetic markers.
6
The degree of relatedness between donor and recipient or between parental organisms.
7
The description of identification and detection techniques.
8
The sensitivity, reliability (in quantitative terms) and specificity of detection and identification techniques.
9
The description of the geographic distribution and of the natural habitat of the organisms including information on natural predators, prey, parasites and competitors, symbionts and hosts.
10
The organisms with which transfer of genetic material is known to occur under natural conditions.
11
Verification of the genetic stability of the organisms and factors affecting that stability.
12
The following pathological, ecological and physiological traits:–
- (a) the classification of hazard according to assimilated law concerning the protection of human health and the environment;
- (b) the generation time in natural ecosystems, sexual and asexual reproductive cycle;
- (c) information on survivability, including seasonability and the ability to form survival structures, including seeds, spores and sclerotia;
- (d) pathogencity, including infectivity, toxigenicity, virulence, allergenicity, carrier (vector) of pathogen, possible vectors, host range including non-target organisms and possible activation of latent viruses (proviruses) and ability to colonise other organisms;
- (e) antibiotic resistance, and potential use of these antibiotics in humans and domestic organisms for prophylaxis and therapy; and
- (f) involvement in environmental processes, including primary production, nutrient turnover, decomposition of organic matter and respiration.
2
3
4
5
6
7
8
9
10
11
12
For paragraphs (d) and (e) of the Schedule to the Scotland Act 1998 (Agency Arrangements) (Specification) (No. 2) Order 2002 substitute–
(ca) Section 126(5)(b) of the Environmental Protection Act 1990 (function of consulting the Food Standards Agency). (cb) Regulation 16(5) of the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002 (function of consideration whether applicant may omit certain information from an application for consent to market genetically modified organisms). (cc) Regulation 20 of the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002 (functions on receiving applications for consent to release genetically modified organisms). (cd) Regulation 23(1) of the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002 (functions on receipt of applications for consent to market genetically modified organisms). (ce) Regulations 23(4) and 31(4) of the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002 (function of consulting the Health and Safety Executive). (cf) Regulation 27(2) of the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002 (function of evaluating information in environmental risk assessments). (cg) Regulation 35 of the Genetically Modified Organisms (Deliberate Release) (Scotland) Regulations 2002 (function of maintaining the register).
Editorial notes
1972 c.68; section 2(2) was amended by the Scotland Act 1998 (c.46), Schedule 8, paragraph 15(3). The function conferred upon the Minister of the Crown under section 2(2) of the European Communities Act 1972, insofar as within devolved competence, was transferred to the Scottish Ministers by virtue of section 53 of the Scotland Act 1998.
S.I. 1992/3280, as amended by S.I. 1993/152, 1995/304, 1997/1900 and 2000/2831.
Section 106(4) is amended by regulation 3(3) and section 106(4A) to (4D) is inserted by regulation 3(4).
As defined in section 107(2), (3) and (6) of the Act as amended by regulation 4(2) to (4).
Section 111(6A) was added by S.I. 1992/3280.
As defined in section 107(2), (3) and (6) of the Act as amended by regulation 4(2) to (4).
Section 112(5)(b)(iii) has been inserted by regulation 29(3)(iii).
Words in reg. 2 substituted (15.11.2004) by The Genetically Modified Organisms (Deliberate Release) (Scotland) Amendment Regulations 2004 (S.S.I. 2004/439), regs. 1, 3(a)
Words in reg. 2 inserted (15.11.2004) by The Genetically Modified Organisms (Deliberate Release) (Scotland) Amendment Regulations 2004 (S.S.I. 2004/439), regs. 1, 3(b)
Words in reg. 15(a) added (15.11.2004) by The Genetically Modified Organisms (Deliberate Release) (Scotland) Amendment Regulations 2004 (S.S.I. 2004/439), regs. 1, 4(a)
Reg. 21(2) substituted (15.11.2004) by The Genetically Modified Organisms (Deliberate Release) (Scotland) Amendment Regulations 2004 (S.S.I. 2004/439), regs. 1, 6
Words in reg. 2(1) substituted (1.4.2015) by The Food (Scotland) Act 2015 (Consequential and Transitional Provisions) Order 2015 (S.S.I. 2015/100), arts. 1(2), 2, sch. para. 8
Words in reg. 32(6) substituted (1.4.2015) by The Food (Scotland) Act 2015 (Consequential and Transitional Provisions) Order 2015 (S.S.I. 2015/100), arts. 1(2), 2, sch. para. 8
Words in reg. 2(1) substituted (15.3.2019) by The Genetically Modified Organisms (Deliberate Release etc.) (Miscellaneous Amendments) (Scotland) Regulations 2019 (S.S.I. 2019/86), regs. 1(1), 3(c)
Words in reg. 2(1) substituted (15.3.2019) by The Genetically Modified Organisms (Deliberate Release etc.) (Miscellaneous Amendments) (Scotland) Regulations 2019 (S.S.I. 2019/86), regs. 1(1), 3(d)
Words in reg. 2(1) substituted (15.3.2019) by The Genetically Modified Organisms (Deliberate Release etc.) (Miscellaneous Amendments) (Scotland) Regulations 2019 (S.S.I. 2019/86), regs. 1(1), 3(e)
Words in reg. 2(1) substituted (15.3.2019) by The Genetically Modified Organisms (Deliberate Release etc.) (Miscellaneous Amendments) (Scotland) Regulations 2019 (S.S.I. 2019/86), regs. 1(1), 3(f)
Words in reg. 2(1) omitted (15.3.2019) by virtue of The Genetically Modified Organisms (Deliberate Release etc.) (Miscellaneous Amendments) (Scotland) Regulations 2019 (S.S.I. 2019/86), regs. 1(1), 3(g)
Reg. 13 omitted (15.3.2019) by virtue of The Genetically Modified Organisms (Deliberate Release etc.) (Miscellaneous Amendments) (Scotland) Regulations 2019 (S.S.I. 2019/86), regs. 1(1), 6
Reg. 15 renumbered as reg. 15(1) (15.3.2019) by The Genetically Modified Organisms (Deliberate Release etc.) (Miscellaneous Amendments) (Scotland) Regulations 2019 (S.S.I. 2019/86), regs. 1(1), 7(a)
Reg. 15(1)(f) and word omitted (15.3.2019) by virtue of The Genetically Modified Organisms (Deliberate Release etc.) (Miscellaneous Amendments) (Scotland) Regulations 2019 (S.S.I. 2019/86), regs. 1(1), 7(d)
Words in reg. 2(1) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(2)
Words in reg. 9 inserted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(3)(a)
Words in reg. 9 substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(3)(b)
Words in reg. 9 substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(3)(c)
Words in reg. 11(1)(b) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(4)
Word in reg. 15(1) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(5)(a)
Words in reg. 15(1) omitted (28.3.2019) by virtue of The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(5)(b)(i)
Word in reg. 15(1) omitted (28.3.2019) by virtue of The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(5)(b)(ii)
Words in reg. 15(1) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(5)(c)
Words in reg. 15(1)(a) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(5)(d)(i)
Words in reg. 15(1)(a) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(5)(d)(ii)
Words in reg. 25(1)(c)(ii) inserted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(7)(a)(ii)
Words in reg. 26(4) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(8)(a)
Words in reg. 26(6) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(8)(c)
Word in reg. 29A(1)(a) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(11)(a)(i)
Words in reg. 29A(1)(a) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(11)(a)(ii)
Words in reg. 29A(3)(a) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(11)(b)(i)
Word in reg. 29A(3)(b) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(11)(b)(ii)
Words in reg. 29A(6) inserted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(11)(c)
Words in reg. 29A(7) inserted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(11)(d)
Words in reg. 29A(11) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(11)(e)
Word in reg. 29A(12)(a) inserted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(11)(f)(i)
Words in reg. 29A(12)(a) inserted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(11)(f)(ii)
Words in reg. 29B(1)(a) inserted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(12)(a)(i)
Words in reg. 29B(1)(a) inserted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(12)(a)(ii)
Words in reg. 29B(1)(a) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(12)(a)(iii)
Words in reg. 29B(1)(b) inserted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(12)(b)
Word in reg. 30A(1)(a)(i) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(13)(a)(i)(aa)
Word in reg. 30A(1)(a)(i) omitted (28.3.2019) by virtue of The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(13)(a)(i)(bb)
Word in reg. 30A(1)(a)(ii) inserted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(13)(a)(ii)
Words in reg. 30A(1)(b) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(13)(b)(i)
Words in reg. 30A(1)(b) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(13)(b)(ii)
Words in reg. 30A(1)(c) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(13)(c)
Words in reg. 30A(1)(d) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(13)(d)
Words in reg. 32B(1)(d) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(14)(a)(i)
Words in reg. 32B(1)(d) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(14)(a)(ii)
Words in reg. 32B(1)(e) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(14)(b)
Words in reg. 34(3)(h) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(15)(a)(i)
Word in reg. 34(3)(h) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(15)(a)(ii)
Word in reg. 34(7) substituted (28.3.2019) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(a), 2(15)(b)
Words in reg. 2(1) substituted (31.12.2020) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(b), 3(2)(a); 2020 c. 1, Sch. 5 para. 1(1)
Words in reg. 2(1) omitted (31.12.2020) by virtue of The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(b), 3(2)(b); 2020 c. 1, Sch. 5 para. 1(1)
Words in reg. 2(1) omitted (31.12.2020) by virtue of The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(b), 3(2)(c); 2020 c. 1, Sch. 5 para. 1(1)
Words in reg. 2(1) inserted (31.12.2020) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(b), 3(2)(d); 2020 c. 1, Sch. 5 para. 1(1)
Words in reg. 6(1)(b) substituted (31.12.2020) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(b), 3(3)(a); 2020 c. 1, Sch. 5 para. 1(1)
Words in reg. 6(1)(b) substituted (31.12.2020) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(b), 3(3)(b); 2020 c. 1, Sch. 5 para. 1(1)
Words in reg. 9 inserted (31.12.2020) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(b), 3(4); 2020 c. 1, Sch. 5 para. 1(1)
Words in reg. 11(1)(b) inserted (31.12.2020) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(b), 3(5)(a)(i); 2020 c. 1, Sch. 5 para. 1(1)
Words in reg. 11(1)(b) omitted (31.12.2020) by virtue of The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(b), 3(5)(a)(ii); 2020 c. 1, Sch. 5 para. 1(1)
Words in reg. 11(1)(d) omitted (31.12.2020) by virtue of The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(b), 3(5)(b)(i); 2020 c. 1, Sch. 5 para. 1(1)
Words in reg. 11(1)(d) inserted (31.12.2020) by The Genetically Modified Organisms (EU Exit) (Scotland) (Amendment) Regulations 2019 (S.S.I. 2019/57), regs. 1(2)(b), 3(5)(b)(ii); 2020 c. 1, Sch. 5 para. 1(1)
Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.
This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence.
legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.